Are you Dr. Ghamande?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
Georgia Regents Medical Associates
Augusta, GA 30912Phone+1 706-721-3993Fax+1 706-721-9777
Summary
- Dr. Sharad Ghamande, MD is an obstetrician/gynecologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia and New York. He is affiliated with WellStar MCG Health, affiliated with Medical College of Georgia, Piedmont Augusta, and University Hospital Summerville.
Education & Training
- Boston University Medical CenterResidency, Obstetrics and Gynecology, 1993 - 1997
- Seth G.S. Medical CollegeClass of 1985
Certifications & Licensure
- GA State Medical License 2000 - 2025
- NY State Medical License 1997 - 2001
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomiz...Matthew A Powell, David Cibula, David M O'Malley, Ingrid Boere, Mark S Shahin
Gynecologic Oncology. 2024-11-11 - Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes.Jennifer Vaz, Rachael Piver, Bogna Brzezinska, Jessa Suhner, Sneha Sareddy
Gynecologic Oncology. 2024-10-01 - 3 citationsA non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCR...Ritu Salani, Mary McCormack, Yong-Man Kim, Sharad Ghamande, Shaundra L Hall
International Journal of Gynecological Cancer. 2024-08-05
Press Mentions
- How Gaps in Health Insurance Coverage Haunt Vulnerable PatientsAugust 24th, 2021
- Georgia Cancer Center Receives $6 Million Grant to Improve Access to Clinical TrialsSeptember 14th, 2019
- Georgia Cancer Center CaRES Receives $6M for Clinical Trials for Minorities & Underserved PopulationsSeptember 14th, 2019
- Join now to see all
Professional Memberships
- Fellow